Comparative analysis of haemostatic proteinases: Structural aspects of thrombin, factor Xa, factor IXa and protein C

Thrombosis and Haemostasis

Volumn 78, Issue 1, 1997, Pages 501-511

  Bode, Wolfram ^a   Brandstetter, Hans ^b   Mather, Timothy ^c   Stubbs, Milton T ^d  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9A; PROTEIN C; PROTEIN S; PROTEINASE; SERINE PROTEINASE; THROMBIN;

ANTICOAGULATION; BLOOD CLOTTING; COMPARATIVE STUDY; CONFERENCE PAPER; FIBRINOLYSIS; HEMOSTASIS; PRIORITY JOURNAL; PROTEIN STRUCTURE;

EID: 0030811924     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1657577     Document Type: Conference Paper

References (97)

1. Davie, E.W., Fujikawa, K., and Kisiel, W. The coagulation cascade: Initiation, maintenance, and regulation. Biochemistry 30, 10364-10370, 1991.
2. Ruf W., and Edgington, T.S. Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEB J. 8, 385-390, 1994.
3. Mann, K.G. The assembly of blood clotting complexes on membranes. Trends Biochem. Sci. 12, 229-233, 1987.
4. Esmon, C.T. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J. Biol. Chem. 264, 4743-4746, 1989.
5. Stubbs, M.T. & Bode, W. Coagulation factors and their inhibitors. Curr. Op. Struct. Biol., 1994, 4, 823-832.
6. Bode, W., Mayr, I., Baumann, U., Huber, R., Stone, S.R. & Hofsteenge, J. The refined 1.9 Å crystal structure of human a-thrombin: Interaction with D-Phe-Pro-Arg chloromethlyketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J. 8, 3467-3475, 1989.
7. Bode, W., Turk, D., and Karshikov, A. The refined 1.9 Å X-ray crystal structure of D-PheProArg chloromethylketone inhibited human a-thrombin. Structure analysis, overall structure, electrostatic properties, detailed active site geometry, structure-function relationships. Protein Sci. 1, 426-471, 1992.
8. Stubbs, M.T. & Bode, W. A player of many parts: the spotlight falls on thrombin's structure. Thrombosis Research 69, 1-58, 1993.
9. Stubbs, M.T. & Bode, W. (1995) The clot thickens... clues provided by thrombin structure Trends Biochem. Sci. 20, 23-28
10. Padmanabhan, K., Padmanabhan, KP., Tulinsky, A., Park, C.H., Bode, W., Huber, R., Blankenship, D.T., Cardin, A.D. & Kisiel, W. (1993) Structure of human des(1-45) Factor Xa at 2.2 Å resolution. J. Mol. Biol. 232, 947-966.
11. Brandstetter, H., Kühne, A., Bode, W., Huber, R., von der Saal, W., Wirthensohn, K. & Engh, R.A. (1996). X-ray structure of the active site inhibited clotting factor Xa: Implications for drug design and substrate recognition. J. Biol. Chem. 271, 29988-29992.
12. Brandstetter, H., Bauer, M., Huber, R., Lollar, P. & Bode, W. (1995). X-ray structure of clotting factor IXa: Active site and module structure related to Xase activity and hemophilia B. Proc. Natl. Acad. Sci. USA. 92, 9796-9800.
13. Mather, T., Oganessyan, V., Hof, P., Huber, R., Foundling, S., Esmon, C., and Bode, W. (1996) The 2.8 Å crystal structure of Gla-domainless activated protein C. EMBO J. 15, 6822-6831.
14. Banner, D.W., D'Arcy, A., Chene, C., Winkler, F.W, Guha, A., Konigsberg, W.H., Nemerson, Y. & Kirchhofer, D. (1996) The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature 380, 41-46.
15. Banner, D.W. (this volume, p. 512)
16. Carrell, R.W. (this volume, p. 516)
17. Seshadri, T.P., Tulinsky, A., Skrzypczak-Jankun, E., and Park, C.H. Structure of bovine prothrombin fragment 1 refined at 2.25 Å resolution. J. Mol. Biol. 220, 481-494, 1991.
18. 2+ free Gla domain sheds light on membrane binding of blood coagulation factors. Nature Struct. Biol. 2, 504-509.
19. Freedman, S.J., Furie, B.C., Furie, B. & Baleja, J.D. (1995) Structure of the metal-free gamma-carboxyglutamic acid-rich membrane binding region of factor IX by two-dimensional NMR spectroscopy. J. Biol. Chem. 270, 7980-7989.
20. 2+ ion and membrane binding structure of the Gla domain of Ca-prothrombin fragment 1. Biochemistry 31, 2554-2566, 1992.
21. Freedman SJ, Furie BC, Furie B, Baleja JD (1995) Structure of the calcium ion-bound gamma-carboxyglutamic acid-rich domain of factor IX. Biochemistry 34, 12126-12137.
22. Freedman SJ, Blostein MD, Baleja JD, Jacobs M, Furie BC, Furie B (1996) Identification of the phospholipid binding site in the vitamin K-dependent blood coagulation protein factor IX. J. Biol. Chem. 271, 16227-16236.
23. Huber, R. & Bode, W. (1978) Structural basis of the activation and action of trypsin. Accounts of Chemical Research 11, 114-122.
24. van Dieijen, G., Tans, G., Rosing, J. & Hemker, H.C. (1981) The role of phospholipid and factor VIIIa in the activation of bovine factor X. J. Biol. Chem. 256, 34333-3442.
25. Mann, K.G., Nesheim, M.E., Church, W.R., Haley, P. & Krishnaswamy, S. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood 76, 1-16, 1990.
26. Coughlin S.R. (1994) Thrombin receptor function and cardiovascular disease. Trends Cardiovasc. Med. 4, 77-83.
27. Olson, S.T. & Björk, I. (1992) Regulation of thrombin by antithrombin and heparin cofactor II. In Thrombin: Structure and function. (Ed. Berliner, L.J.), New York, Plenum Press, pp. 159-217
28. Ascenzi, P., Coletta, M., Amiconi, G., De Cristofaro, R., Bolognesi, M., Guarneri, M. & Menegatti, E. (1988) Binding of the bovine pancreatic trypsin inhibitor (Kunitz) to human a-, b- and g-thrombin; a kinetic and thermodynamic study. Biochim. Biophys. Acta 956, 156-161.
29. Priestle, J.P., Rahuel, J., Rink, H., Tones, M. & Grütter, M.G. (1993). Changes in interactions in complexes of hirudin derivatives and human a-thrombin due to different crystal forms. Protein Science 2, 1630-1642.
30. Engh, R., Brandstetter, H., Sucher, G., Baumann, U., Kühne, A., Eichinger, A., Bode, W., Huber, R., Poll, T., Rudolph, R. & von der Saal, W. (1996) Enzyme flexibility, solvent and 'weak' interactions characterize thrombin-ligand interactions: implications for drug design. Structure 15, 1353-1362.
31. Rydel, T.J., Tulinsky, A., Bode, W. & Huber, R. (1991). Refined Structure of the Hirudin - Thrombin Complex. J. Mol. Biol. 221 583-601.
32. van de Locht, A., Lamba, D., Bauer, M., Huber, R., Friedrich, T., Kroger, B., Höffken, W. & Bode, W. (1995) Two heads are better than one: crystal structure of the insect derived double domain Kazal inhibitor rhodniin in complex with thrombin. EMBO J., 14, 5149-5157.
33. van de Locht, A., Stubbs, M.T., Bode, W., Friedrich, T., Bollschweiler, C., Höffken, W. & Huber, R. (1996) The Ornithodorin:Thrombin Crystal Structure, a Key to the TAP Enigma? EMBO J., 15, 6011-6017.
34. Stubbs, M.T., Oschkinat, H., Mayr, I., Huber, R., Angliker, H., Stone, S.R. & Bode, W. The interaction of thrombin with fibrinogen - a structural basis for its specificity. Eur. J. Biochem. 206, 187-195, 1992.
35. Martin, P.D., Robertson, W., Turk, D., Bode, W. & Edwards, B.F.P. (1992) The structure of residues 7-16 of the Aa-chain of human fibrinogen bound to bovine thrombin at 2.3 A resolution. J. Biol. Chem. 267, 7911-7920.
36. Stubbs, M.T. & Bode, W. (1993) A model for the specificity of fibrinogen cleavage by thrombin. Semin. Thromb. Hemost. 19, 344-351.
37. Qiu, X., Padmanabhan, K., Carperos, V.E., Tulinsky, A., Kline, T., Maraganore, J.M., and Fenton, J.W.II. The structure of the hirulog3-thrombin complex and the nature of the S' subsites of substrates and inhibitors. Biochemistry 31, 11689-11697, 1992.
38. Martin, P.D., Malkowski, M.G., DiMaio, J., Konishi, Y., Ni, F. & Edwards, B.F.P. (1996) Bovine thrombin complexed with an uncleavable analog of residues 7-19 of fibrinogen Aa: Geometry of the catalytic triad and interactions of the P1', P2' and P3' substrate residues. Biochemistry 35, 13030-13039.
39. Stephens, A.W., Thalley, B.S. & Hirs, C.H.W. (1987) Antithrombin-III Denver, a reactive site variant. J. Biol. Chem. 262, 1044-1048
40. Stephens, A.W., Siddiqui, A. & Hirs, C.H.W. (1988) Site directed mutagenesis of the reactive center (Serine 394) of antithrombin III. J. Biol. Chem. 263, 15849-15852
41. Theunissen, H.J.M., Dijkema, R., Grootenhuis, P.D.J., Swinkels, J.C., Poorter, T.L., Carati, P., and Visser, A. (1993) Dissociation of heparin-dependent thrombin and factor Xa inhibitory activities of antithrombin-III by mutations in the reactive site. J. Biol. Chem. 268, 9035-9040
42. Morenweiser, R., Auerswald, E.A., van de Locht, A., Fritz, H., Stürzebecher, J. & Stubbs, M.T. Structure-based design of a potent chimeric thrombin inhibitor. Submitted for publication.
43. Wu, Q., Sheehan, J.P., Tsiang, M., Lentz, S.R., Birktoft, J.J. & Sadler, J.E. (1991) Single amino acid substitutions dissociate fibrinogen-clotting and thrombomodulin-binding activities of human thrombin. Proc. Natl. Acad. Sci. USA. 88, 6775-6779.
44. Tsiang, M., Jain, A.K., Dunn, K.E., Rojas, M.E., Leung, L.L.K. & Gibbs, C.S. (1995) Functional mapping of the surface residues of human thrombin. J. Biol. Chem. 270, 16854-16863.
45. Le Bonniec, B.F., Myles, T., Johnson, T., Knight, C.G., Tapparelli, C. & Stone, S.R. (1996) Characterization of the P2' and P3' specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesis. Biochemistry 35, 7114-7122.
46. Le Bonniec, B.F. & Esmon, C.T. (1991). Glu192®Gln substitution in thrombin mimics the catalytic switch induced by thrombomodulin. Proc. Natl. Acad. Sci. USA, 88, 7371-7375.
47. Le Bonniec, B.F., MacGillivray, R.T. & Esmon, C.T. (1991) Thrombin Glu39 restricts the P3' specificity to nonacidic residues. J. Biol. Chem., 266, 13796-13803
48. Griffith, M.J., Noyes C.M., Tyndall, J.A. & Church, F.C. (1985) Structural evidence for leucine at the reactive site of heparin cofactor II. Biochemistry 24, 6777-6782
49. Ragg, H. (1986) A new member of the plasma protease inhibitor gene family. Nucleic Acids Research. 14, 1073-1088.
50. Van Deerlin, V.M.D., and Tollefsen, D.M. (1991) The N-terminal acidic domain of heparin cofactor II mediates the inhibition of a-thrombin in the presence of glycosaminoglycans. J. Biol. Chem. 266, 20223-20231.
51. Ragg, H., Ulshofer, T., and Gerewitz, J (1990) On the activation of human Leuserpin-2, a thrombin inhibitor, by glycosaminoglycans. J. Biol. Chem. 265, 5211-5218.
52. Rogers, S.J., Pratt, C.W., Whinna, H.C., and Church, F.C. (1992) Role of thrombin exosites in inhibition by heparin cofactor II. J. Biol. Chem. 267, 3613-3617
53. Gershkovich, A.A. (1996) Regulation of thrombin activity by ligand-induced conformational changes: a review. Biochemistry (Moscow) 61, 817-824.
54. +-activated enzyme Biochemistry, 31, 11721-11730
55. Ayala, Y. & di Cera, E. (1994) Molecular recognition by thrombin: role of the slow Æfast transition, site-specific ion binding eregetics and thermodynamic mapping of structural components. J. Mol. Biol. 235, 733-746.
56. + binding site of thrombin. J. Biol. Chem. 270, 22089-22092.
57. Gibbs, C.S., Coutre, S.E., Tsiang, M., Li, W.-X., Jam, A.K., Dunn, K.E., Law, V.S., Mao, C.T., Matsumura, S.Y., Mejza, S.J., Paborsky, L.R. & Leung, L.L.K. (1995) Conversion of thrombin into an anticoagulant by protein engineering. Nature 378, 413-416.
58. Miyata, T., Aruga, R., Umeyama, H., Bezeaud, A., Guillin, M.-C. & Iwanaga, S. (1992) Prothrombin Salakta: Substitution of glutamic acid-466 by alanine reduces the fibrinogen clotting activity and the esterase activity. Biochemistry 31, 7457-7462.
59. Le Bonniec, B.F., Guinto, G.R., and Esmon, C.T. Interaction of thrombin des-ETW with antithrombin III, the Kunitz inhibitors, thrombomodulin and protein C. Structural link between the autolysis loop and the Tyr-Pro-Pro-Trp insertion of thrombin. J. Biol. Chem. 267, 19341-19348, 1992.
60. Parry, M.A.A., Stone, S.R., Hofsteenge, J. & Jackman, P. (1993) Evidence for common structural changes in thrombin induced by active-site or exosite binding. Biochem. J., 290, 665-670
61. de Cristofaro, R., Rocca, B., Bizzi, B. & Landolfi, R. (1993) The linkage between binding of the C-terminal domain of hirudin and amidase activity in human a-thrombin. Biochemical Journal. 289, 475-80
62. de Cristofaro, R., de Candia, E., Picozzi, M. & Landolfi, R. (1995) Conformational transformations linked to active site ligation in human thrombin: effect on the interaction with fibrinogen and the cleavable platelet receptor. J. Mol. Biol., 245, 447-458
63. Skrzypczak-Jankun, E., Carperos, V., Ravichandran, K.G., Tulinsky, A., Westbrook, M., and Maraganore, J. The structure of the hirugen and hirulog 1 complexes of a-thrombin. J. Mol. Biol. 221, 1379-1393, 1991.
64. Mathews, I.I., Padmanabhan, K.P. und Tulinsky, A. (1994) Structure of a nonadecapeptide of the fifth EGF domain of thrombomodulin complexed with thrombin. Biochemistry, 33, 13547-13552.
65. Vijayalakshmi, J., Padmanabhan, K.P., Mann, K.G. & Tulinsky, A. (1994) The isomorphous structures of prethrombin 2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin. Protein Sci. 3, 2254-2271.
66. Ye, J., Esmon, N.L., Esmon, C.T. & Johnson A.E. (1991) The active site of thrombin is altered upon binding to thrombomodulin. J. Biol. Chem., 266, 23016-23021
67. 192 → Gln substitution in thrombin yields an enzyme that is effectively inhibited by bovine pancreatic trypsin inhibitor and tissue factor pathway inhibitor. J. Biol. Chem. 269, 18395-18400.
68. Rezaie, A.R. & Esmon, C.T. (1995) Contribution of residue 192 in factor Xa to enzyme specificity and function. J. Biol. Chem. 270, 16176-16181.
69. Neuenschwander, P.F. & Morrissey, J.H. (1995) Alteration of the substrate and inhibitor specificities of blood coagulation factor VIIa: Importance of amino acid residue K192. Biochemistry 34, 8701-8707.
70. Rezaie, A., and Esmon, C. (1993) Conversion of glutamic acid 192 to glutamine in activated protein C changes the substrate specificity and increases reactivity toward macromolecular inhibitors. J. Biol. Chem. 268, 19943-19948
71. Duffy, E.J., Angliker, H., LeBonniec, B.F. & Stone, S.R. (1997) Allosteric modulation of the activity of thrombin. Biochem. J. 321, 361-365.
72. Friedrich, T., Kröger, B., Biolajan, S., Lemaire, H.G., Höffken, H.W., Reuschenbach, P., Otte, M., and Dodt, J. (1993) A Kazal-type inhibitor with thrombin specificity from Rhodnius prolixus. J. Biol. Chem. 268, 16216-16222
73. Le Bonniec, B.F., Guinto, E.R., MacGillivray, R.T., Stone, S.R. & Esmon, C.T. (1993) The role of thrombin's Tyr-Pro-Pro-Trp motif in the interaction with fibrinogen, thrombomodulin, protein C, antithrombin III, and the Kunitz inhibitors. J. Biol. Chem., 268, 19055-19061
74. van de Locht, A., Bode, W., Huber, R., Le Bonniec, B.F., Stone, S.R., Esmon, C.T. & Stubbs, M.T. (1997). The thrombin E192Q:BPTI-complex reveals gross structural rearrangements: implications for the interaction with antithrombin. EMBO J., in the press.
75. Engh, R.A., Huber, R., Bode, W. & Schulze, A.J. (1995) Divining the serpin inhibition mechanism: a suicide substrate 'springe'? Trends Biotech., 13, 503-510
76. 1-antitrypsin. Biochemistry, 34, 12241-12248
77. Rezaie, A.R. (1996) Tryptophan 60D in the B-insertion loop of thrombin modulates the thrombin-antithrombin reaction Biochemistry, 35, 1918-1924
78. Krishnaswamy, S., Church, W.R., Nesheim, M.E. & Mann, K.G. (1987) Activation of human prothrombin by prothrombinase. Influence of factor Va on the reaction mechanism. J. Biol. Chem. 262, 3291-3299.
79. Doyle, M.F. & Mann, K.G. (1990) Multiple active forms of thrombin. IV. Relative activities of meizothrombins. J. Biol. Chem. 265, 10693-10701.
80. Kaczmarek, E., Kaminski, M. & McDonagh, J. (1987) Fibrinogen-sepharose interaction with prothrombin, prethrombin 1, prethrombin 2 and thrombin. Biochim. Biophys. Acta 914, 275-282.
81. Ami, R.K., Padmanabhan, K., Padmanabhan, K.P., Wu, T.P. & Tulinsky, A. Structures of the non-covalent complexes of human and bovine prothrombin fragment 2 with human PPACK-thrombin. Biochemistry 32, 4727-4737, 1993.
82. Liu, L.-W., Ye, J., Johnson, A.E. & Esmon, C.T. Proteolytic formation of either of the two prothrombin activation intermediates results in formation of a hirugen binding site. J. Biol. Chem. 266, 23632-23636, 1991.
83. Ni, F., Ning, Q., Jackson, C.M. & Fenton, J.W.II (1993) Thrombin exosite for fibrinogen recognition is partially accessible in prothrombin. J. Biol. Chem. 268, 16899-16902.
84. van de Locht, A., Stubbs, M.T., Bauer, M. & Bode, W. (1996) Crystallographic evidence that the F2 Kringle catalytic domain linker of prothrombin does not cover the fibrinogen recognition exosite. J. Biol. Chem. 271, 3413-3416.
85. Burgering, M.J.M, Orbons, L.P.M., van der Doelen, A., Mulders, J., Theunissen, H.J.M., Grootenhuis, P.J.M., Bode, W., Huber, R. & Stubbs, M.T. (1997) The second Kunitz domain of human tissue factor pathway inhibitor. Cloning, structure determination and interaction with factor Xa. J. Mol. Biol., in the press.
86. Stubbs, M.T., Huber, R. & Bode, W (1995) Crystal structures of factor Xa specific inhibitors in complex with trypsin: Structural grounds for inhibition of factor Xa and selectivity against thrombin FEBS Lett. 375, 103-107.
87. Stubbs, M.T. (1996) Structural aspects of factor Xa inhibition. Current Pharmaceutical Design 2, 543-552.
88. Broze, G.J.Jr. (1995) Tissue factor pathway inhibitor. Thromb. Haemost 74, 90-93.
89. Castillo, M.J., Kurachi, K., Nishino, N., Okkubo, F. & Powers, J.C. (1983) Reactivity of bovine blood coagulation factor IXa beta, factor Xa beta, and factor XIa toward fluorogenic peptides containing the activation site sequences of bovine factor IX and factor X. Biochemistry 22, 1021-1029.
90. Kam, C.M., Kerrigan, J.E., Plaskon, R.R., Duffy, E.J., Lollar, P., Suddath, F.L. & Powers, J.C. (1994) Mechanism-based isocoumarin inhibitors for blood coagulation serine proteases. Effect of the 7-substituent in 7-amino-4-chloro-3-(isothioureidoalkoxy)isocoumarins on inhibitory and anticoagulant potency. J. Med. Chem. 37, 1298-1306.
91. 2+ binding to the first EGF domain. A combined NMR-small angle X-ray scattering study. Biochemistry 35, 11547-11559
92. Bottema, C.D., Ketterling, R.P., Ii, S., Yoon, H.S., Phillips, J.A.III. & Sommer, S.S. (1991) Missense mutations and evolutionary conservation of amino acids: evidence that many of the amino acids in factor IX function as "spacer" elements. Am. J. Hum. Genet. 49, 820-838.
93. Roberts, H.R. (1993) Molecular biology of hemophilia B. Thromb. Haemost. 70, 1-9.
94. Gianelli, F., Green, P.M., Sommer, S.S., Lillicrap, D.P., Ludwig, M., Schwaab, R., Reitsma, P.H., Goossens, M. & Brownlee, G.G. (1994) Haemophilia B: database of point mutations and short additions and deletions, fifth edition, 1994. Nucleic Acids Res. 22, 3534-3546.
95. Pratt, C.W., Whinna, H.C. & Church, F.C. (1992) A comparison of three heparin-binding serine protease inhibitors. J. Biol. Chem. 267, 8795-8801.
96. Hermans, J.M. & Stone, S.R. (1993) Interaction of activated protein C with serpins. Biochem. J. 295, 239-245
97. Holly, R. & Foster, D.C. (1994) Resistance to inhibition by al-antitrypsin and species specificity of a chimeric human/bovine protein C. Biochemistry 33, 1876-1880.